Weekly healthcare intelligenceRegulation · Enforcement · Government payersAll editions →

Compliance Sweep · November 15, 2026

The leading stories for your work. Choose a topic to focus the front page.

Published November 15, 2026 · Reporting window November 8–14, 2026, Pacific. Later developments are labelled. Source coverage is incomplete; the complete reports describe the limitations.

Showing 15 of 27 articles and reminders.

Illustrative artwork
Governance & business operationsCompliance SweepUpdated

Medline bed recall: seven deaths and 35 serious injuries now reported; repair-and-replace customer guides coming

On November 13, 2026, FDA posted a Medline company announcement updating customers and patients on the repair and replace program for the recall of Medline Brand beds, rails, mattresses and accessories. Medline says that as of November 8, 2026 it has received reports related to seven deaths and 35 serious injuries associated with the fire hazard and entrapment issues, up from the two deaths and 16 serious injuries FDA's early alert reported as of October 20, 2026. Medline says it distributed the products in the United States and Canada between 2011 and 2026 to durable medical equipment providers, long-term care facilities and end users, and that it will soon begin distributing new repair and replace Customer Guides to patients and users. The continued-use instructions are unchanged: unplug the beds, plug in only while repositioning the patient, do not use extension cords, and have a second person assist whenever possible. To determine eligibility for repair, replacement or refund, customers contact the provider or distributor they bought or received the bed from, or Medline Recall Customer Service if they bought directly from Medline. On November 15, 2026, FDA's early alert page still showed content current as of October 29, 2026.

High priority · Nov 15, 2026 editionRead story →

Illustrative artwork
Governance & business operationsCompliance SweepNew in this edition

FDA early alert: Arrow International removes catheters and guidewires with hydrophilic-coated spring wire guides over coating detachment and embolism risk

The Food and Drug Administration (FDA) posted an early alert on November 10, 2026 about Arrow International, a subsidiary of Teleflex Incorporated, which has told customers to remove certain products that contain Spring Wire Guide components. Arrow sent the letter on November 5, 2026, telling customers to check inventory, stop using and distributing affected product, quarantine it and return it. Teleflex confirmed that the hydrophilic coating may swell unevenly when hydrated with saline, clump and potentially detach. Detached coating could release particles into the bloodstream and raise the risk of emboli. As of November 5, 2026, the firm had reported no serious injuries or deaths.

High priority · Nov 15, 2026 editionRead story →

Illustrative artwork
Governance & business operationsCompliance SweepNew in this edition

FDA early alert: Intersurgical removes lots of 22mm Smoothbore breathing tubes and systems over connector disconnection and loss of ventilation risk

The Food and Drug Administration (FDA) posted an early alert on November 10, 2026 about Intersurgical Inc., which has told customers to remove listed lots of its 22mm Smoothbore breathing tubes and systems. Intersurgical sent the letter on November 3, 2026, telling customers to stop using and quarantine stock with the affected product and lot numbers and return it. Testing of internal stock found some products were made with too little solvent to secure the soft connectors to the tube. A connector that disconnects during use could cause loss of ventilation or compromised ventilation. As of November 3, 2026, the firm had reported no serious injuries or deaths.

High priority · Nov 15, 2026 editionRead story →

Illustrative artwork
Governance & business operationsCompliance SweepConditional reminder

Eugia recalls one lot of vancomycin injection to the hospital level for glass particulate

Eugia US LLC announced on November 6, 2026 a voluntary nationwide recall, to the hospital/healthcare facility/user level, of one lot (3VM26026A) of Vancomycin Hydrochloride for Injection USP (United States Pharmacopeia) 1.25g/Vial-30mL because a glass particle was found inside a vial; FDA posted the announcement on November 9, 2026. The lot shipped to wholesalers nationwide from September 2 through September 15, 2026, and holders are told to discontinue use and quarantine it immediately.

High priority · Nov 15, 2026 editionRead story →

Illustrative artwork
Governance & business operationsCompliance SweepConditional reminder

FDA early alert: ButterflyBVM bag-valve-mask resuscitators, removal of lots 000109 to 000117 and pre-use test for others

The Food and Drug Administration (FDA) issued an Early Alert on November 3, 2026 about Compact Medical's "Urgent Medical Device Recall" for certain lots of ButterflyBVM single-use bag-valve-mask resuscitators: lots 000109 through 000117 are to be removed, and listed earlier lots get a correction, to perform the Pre-Use Test before every use and not use any unit that fails. A hole can form in the bellows, which FDA says can cause inadequate ventilation and hypoxia; the firm sent letters on September 26 and October 7, 2026.

High priority · Nov 15, 2026 editionRead story →

More in this edition

Read all 27 articles and reminders →

Privacy preferences

Where enabled for this site, Cloudflare Web Analytics can send page-use and performance measurements to Cloudflare. This panel provides information and does not turn analytics on or off.

This panel stores no tracking choice and does not change your tool saves, screening, resets, reports or exports. Other sites have separate settings.

Read Privacy & Cookies